A flexible vision-tabular method is deployed to incorporate cine CMR into CVD risk assessment together with structured clinical data and it is demonstrated that integrating cine CMR with clinical variables through a vision-tabular learning framework stabilizes risk prediction under real-world conditions of incomplete tabular data.
Abstract
Early and accurate risk stratification of cardiovascular disease (CVD) is crucial to initiate timely preventive interventions. As large-scale multimodal clinical cohorts become increasingly available, there is growing interest in whether incorporating additional sources of information can improve CVD risk stratification. Cine cardiac MR (CMR) represents a compelling example of such a source, as it captures objective, high-dimensional structural and functional information about the heart, independent of patient-reported data. In this study, we deploy a flexible vision-tabular method to incorporate cine CMR into CVD risk assessment together with structured clinical data. Using a large prospective imaging cohort from the UK Biobank, we show that cine CMR encodes CVD risk beyond established risk scores, increasing AUROC by 0.036 over SCORE2, the best-performing traditional risk score (0.742 vs. 0.706, textit{p} = 0.04). Furthermore, we find that cine CMR achieves risk discrimination capabilities on par with automated, image-derived phenotypes, removing the dependency on segmentation pipelines. Lastly, we demonstrate that integrating cine CMR with clinical variables through a vision-tabular learning framework stabilizes risk prediction under real-world conditions of incomplete tabular data, a common challenge in clinical practice. Together, these findings position cine CMR as a promising modality for CVD risk assessment.
It is emphasized that successful integration of AI into cardiovascular care requires rigorous prospective validation, transparent algorithmic governance, equitable data representation, and human-AI collaborative frameworks, provided its meaningful clinical implication is demonstrated through improved patient outcomes.
Xu Xia, Wasim Ullah Khan, Q. Khan et al.· Trends in cardiovascular med...· 0 citations
Atherosclerotic cardiovascular disease (ASCVD) is the leading global cause of death and evolves over decades through a prolonged subclinical phase, providing a critical opportunity for early detection and prevention. Traditional risk prediction models estimate future cardiovascular risk but may under- or overestimate i...
V. Sorin, Kemi Fatade, Michael F. Morris et al.· Radiographics· 0 citations
The developed CARDINAL (Cardiovascular Assessment via Representation learning from Deep Imaging with Nested Anatomical Latent embeddings), a clinically grounded framework that learns compact representations from routine non-contrast cardiac CT for major adverse cardiovascular event (MACE) prediction, suggests that non-...
Roy M. Gabriel, Nattakorn Kittisut, Jamshid Hassanpour et al.· 0 citations
Current evidence supports FAI/FAI-Score primarily as a prognostic marker; trial-level evidence that FAI-guided management decisions improve patient outcomes is not yet available, and substantial technical challenges remain.
M. Hoshino, T. Yonetsu, T. Kakuta et al.· Journal of Cardiology· 0 citations
Cardiovascular (CV) diseases remain the leading cause of mortality in women and often present as the first clinical manifestation, highlighting the limitations of current risk scores. In this context, breast arterial calcifications (BACs), incidentally detected on screening mammography, are emerging as a potential biom...
M. Zuin, G. Rigatelli, C. Bilato· Giornale italiano di cardiol...· 0 citations